grant

A biomimetic prodrug platform to enable oral bioavailability and target lymphatic disease [ 2017 - 2021 ]

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1127889]

Brief description This project will allow the advance of a unique translational technology platform that provides novel drug delivery solutions. The project aims to establish the potential for a drug delivery strategy to increase the efficacy, reduce the toxicity, and transform the impact of drug therapies for a variety of conditions, including pain, hormone dysregulation, and metabolic syndrome.

Funding Amount $AUD 416,661.91

Funding Scheme Early Career Fellowships

Notes Australia-China Exchange ECF

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857